Marina BACAC
24Patents
6h-index
37Co-inventors
65Inventor score
Filing activity: Aug 9, 2011 → May 13, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9011847B2 | Anti-FAP antibodies and methods of use | Chemistry; Metallurgy | 27 | Active |
| US9963513B2 | Method for the selection of antibodies against BCMA | Physics | 17 | Active |
| US10253110B2 | Anti-FAP antibodies and methods of use | Chemistry; Metallurgy | 12 | Active |
| US10577429B2 | Anti-FAP antibodies and methods of use | Chemistry; Metallurgy | 12 | Active |
| US9914776B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 10 | Active |
| US10155815B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 8 | Active |
| US10253104B2 | Bispecific antibodies against CD3ϵ and BCMA | Chemistry; Metallurgy | 6 | Active |
| US10077315B2 | Bispecific antibodies against CD3 and BCMA | Physics | 6 | Active |
| US11332545B2 | Anti-FAP antibodies and methods of use | Chemistry; Metallurgy | 4 | Active |
| US10611841B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 4 | Active |
| US10611840B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 4 | Active |
| US10683369B2 | Monoclonal antibodies against BCMA | Chemistry; Metallurgy | 4 | Active |
| US11718680B2 | Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists | Chemistry; Metallurgy | 2 | Active |
| US11117965B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 2 | Active |
| US11459404B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 2 | Active |
| US10596257B2 | Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodies | Chemistry; Metallurgy | 1 | Active |
| US10781258B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 1 | Active |
| US11013801B2 | Treatment method | Chemistry; Metallurgy | 1 | Active |
| US10781257B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 1 | Active |
| US10851171B2 | Method for the selection of antibodies against BCMA | Physics | 1 | Active |
| US10882918B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 0 | Active |
| US12286486B2 | Anti-FAP antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12139553B2 | T cell activating bispecific antigen binding molecules | Chemistry; Metallurgy | 0 | Active |
| US10766967B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.